ArticleMolecular cancer research : MCR2023

Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.

Jessica Limberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.